| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0009 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.001 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.085 | 0.003 |